Related Experiment Video
Updated: Aug 6, 2026
11:59
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Chimerism in a child with severe combined immunodeficiency: a case report
Anna Aureli1, Daniela Piancatelli, Palmina I Monaco
1C.N.R. Institute for Organ Transplantation and Immunocytology, L'Aquila and Rome Sections, L'Aquila, Italy. a.aureli@itoi.cnr.it
Pediatric Transplantation
|August 17, 2006
Summary
Severe combined immunodeficiency (SCID) is a fatal disorder where children lack T and B cells. This case study reveals blood chimerism in a one-year-old boy with SCID, highlighting maternal T cell presence.
Area of Science:
- Immunology
- Pediatrics
- Genetics
Background:
- Severe combined immunodeficiency (SCID) is a group of rare, congenital disorders characterized by the absence of T-lymphocyte and B-lymphocyte function.
- SCID is fatal within two years of age if left untreated.
- Hematopoietic stem cell transplantation (HSCT) is the primary effective treatment for SCID.
Observation:
- Maternal T cells have been previously observed in the peripheral blood of infants diagnosed with SCID.
- This report details a specific case involving a one-year-old boy diagnosed with SCID.
Findings:
- The study identified blood chimerism in a one-year-old boy with SCID.
- This finding indicates the presence of cells originating from a different individual (maternal T cells) within the patient's bloodstream.
Implications:
- Understanding blood chimerism in SCID cases is crucial for diagnosis and treatment strategies.
- Further research into the mechanisms and implications of maternal T cell engraftment in SCID patients is warranted.
- This case contributes to the existing knowledge base on immune deficiencies and chimerism.
